Authors: Barry Gyman
Mentors: Cody Reeves
Insitution: Brigham Young University
The purpose of this paper is to qualify and analyze the leading driving forces in determining the success of healthcare innovations in a variety of subspaces in the healthcare industry. Health is one of the largest markets in America and is almost universally relied upon. As the systems and technologies of healthcare are innovated and improved upon, the quality and efficiency of this care stands to increase, potentially benefiting both those who provide care, those who receive care, or both. The healthcare industry offers a plethora of niches needing innovating and the potential of high economic return for the producers, and yet only a small portion of innovations are adopted and successfully integrated with some areas having a failure rate approaching or exceeding 90% (Sun et al., 2022)(Jacobs et. al, 2015). What propels these few successful innovations towards adoption that so many other innovations fail to achieve? Through the analysis of dozens of papers researching success robustness in various healthcare fields, such as pharmacology and technological innovation, we will summarize the data in search of shared commonalities among successful innovations.
Sun, D., Gao, W., Hu, H., & Zhou, S. (2022). Why 90% of clinical drug development fails and how to improve it?. Acta pharmaceutica Sinica. B, 12(7), 3049–3062. https://doi.org/10.1016/j.apsb.2022.02.002
Jacobs, S.R., Weiner, B.J., Reeve, B.B. et al. Determining the predictors of innovation implementation in healthcare: a quantitative analysis of implementation effectiveness. BMC Health Serv Res 15, 6 (2015). https://doi.org/10.1186/s12913-014-0657-3